Hepatitis C Information Central

Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

News, Updates and Commentary

Free Newsletter

We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS

CDC: Syringe reuse linked to hepatitis C outbreak
RENO, Nev. (AP) - Federal health officials say a hepatitis C outbreak affecting more than 80 people and exposing tens of thousands more was caused by workers reusing syringes at a Las Vegas clinic. The Centers for Disease Control and Prevention report

Re-use of syringes likely caused hepatitis C outbreak
RENO, Nev. (AP) - A new federal report out today says the staff at a Las Vegas clinic at the center of a hepatitis C outbreak likely caused the transmission of the bloodborne pathogen. The Centers for Disease Control and Prevention says nurses at the

UPDATES AND COMMENTARY

What You Must Know About Alcoholic Hepatitis
This much-needed synopsis of alcoholic hepatitis reminds us that you don't need to be a heavy drinker to suffer from this condition. Looking over the causes, risk factors and complications of alcoholic hepatitis will motivate anyone with liver concerns to...

15 Tips for Managing Interferon-Ribavirin Side Effects
Finding new ways to manage the side effects of Hepatitis C combination therapy adds to a person’s likelihood of conquering the virus....

New Mexico Offers Free Hepatitis C Hotline
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...

Transarterial Embolization Versus Symptomatic Treatment in Patients With Advanced Hepatocellular Carcinoma:
Results of a Randomized, Controlled Trial in a Single Institution

table 1. Baseline Characteristics of the Patients

	TAE Group (n = 40)	Control Group (n = 40)

Age (yr)	61 ± 9	64 ± 8
Sex distribution (male/female)	30/10	30/10
Etiology of hepatic cirrhosis
Hepatitis C virus	29	31
Cryptogenic	5	4
Alcohol	2	1
Hepatitis B virus	2	1
Others	2	3
Presence of ascites (%)	10 (25%)	7 (18%)
Constitutional syndrome (%)	9 (23%)	7 (18%)
Serum bilirubin (mg/dL)	1.2 ± 0.6	1.5 ± 0.7
Prothrombin activity (%)	81 ± 16	79 ± 14
Serum albumin (g/L)	35 ± 4	35 ± 5
Alanine transaminase (UI/L)	89 ± 57	101 ± 75
-Glutamyltranspeptidase (UI/L)	112 ± 114	119 ± 88
Alkaline phosphatase (UI/L)	303 ± 6	343 ± 201
Blood urea nitrogen (mg/dL)	18 ± 5	18 ± 5
-Fetoprotein
100 ng/mL	26	27
>100 ng/mL	14	13
Tumor stage
Solitary	8	11
Multinodular/massive	32	29
Tumor location
Unilobar	24	25
Bilobar	16	15
Child-Pugh score	5.8 ± 0.7	6.0 ± 1.1
Okuda's stage (I/II)	27/13	27/13
PST (0/1/2)	27/11/2	27/11/2

NOTE. There were no significant differences between groups with respect to any of these variables.

[Return To Article]

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.